Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

Mikulska, M

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. [electronic resource] - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Oct 2014 - O694-701 p. digital

Publication Type: Journal Article

1469-0691

10.1111/1469-0691.12611 doi


Adolescent
Adult
Aged
Antibodies, Monoclonal, Murine-Derived--adverse effects
Child
Cyclosporine--adverse effects
Female
Graft vs Host Disease--immunology
Hematopoietic Stem Cell Transplantation--adverse effects
Hepatitis B Surface Antigens--analysis
Hepatitis B virus--physiology
Humans
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Risk Factors
Rituximab
Survival Analysis
Transplant Recipients
Transplantation, Homologous
Treatment Outcome
Virus Activation
Young Adult